These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 21043897)

  • 1. Antiaggregatory Properties of Beta-adrenoceptor Blocking Drugs are Related to their Physico-chemical Properties.
    Nosál R; Jancinová V; Petriková M
    Platelets; 1992; 3(1):29-33. PubMed ID: 21043897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the relationship between the inhibition of thrombin stimulated aggregation and thromboxane formation in isolated platelets treated with beta-adrenoceptor blocking drugs.
    Nosál R; Jancinová V; Petríková M
    Thromb Res; 1992 Dec; 68(4-5):333-44. PubMed ID: 1363256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in lipid peroxidation of thrombin-stimulated rat platelets treated with beta-adrenoceptor blocking drugs.
    Nosál R; Petríková M; Jancinová V
    J Lipid Mediat; 1993 Oct; 8(2):121-32. PubMed ID: 7903565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic amphiphilic drugs and platelet phospholipase A(2) (cPLA(2)).
    Nosál R; Jancinová V
    Thromb Res; 2002 Feb; 105(4):339-45. PubMed ID: 12031829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological intervention with platelet phospholipase A2.
    Nosal R; Jancinova V
    Bratisl Lek Listy; 2001; 102(10):447-53. PubMed ID: 11802290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences among beta-adrenoceptor blocking drugs in modifying platelet aggregation and arachidonic acid liberation under thrombin stimulation.
    Jancinová V; Nosál R
    Thromb Res; 1989 Jun; 54(6):687-98. PubMed ID: 2571198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.
    Petrikova M; Jancinova V; Nosal R; Majekova M; Fabryova V
    Bratisl Lek Listy; 2005; 106(1):20-5. PubMed ID: 15869009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of beta-adrenoceptor blocking drugs with platelet aggregation, calcium displacement and fluidization of the membrane.
    Nosál R; Jancinová V; Ondrias K; Jakubovský J; Balgavý P
    Biochim Biophys Acta; 1985 Dec; 821(2):217-28. PubMed ID: 2865973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of intracellular calcium in A-23187 stimulated and beta-adrenoceptor blocking drug treated blood platelets.
    Nosál R; Jancinová V; Petríková M
    Biochem Pharmacol; 1994 Jun; 47(12):2207-11. PubMed ID: 7913320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of arachidonic acid and its metabolites in the inhibitory effect of beta-adrenoceptor blocking drugs on blood platelets.
    Nosál R; Jancinová V; Petríková M
    Agents Actions Suppl; 1992; 37():47-52. PubMed ID: 1352937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
    Mizogami M; Takakura K; Tsuchiya H
    Eur J Anaesthesiol; 2010 Sep; 27(9):829-34. PubMed ID: 20601889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the relationship between aggregation and cyclic nucleotides in platelets treated with betaadrenoceptor blocking drugs.
    Nosál R; Jancinová V; Petríková M
    Gen Physiol Biophys; 1983 Oct; 2(5):353-62. PubMed ID: 6147296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the potency of five potential beta-adrenoceptor blocking drugs and eight calcium channel blockers to inhibit platelet aggregation and to perturb liposomal membranes prepared from platelet lipids.
    Ondriasová E; Ondrias K; Stasko A; Nosál R; Csöllei J
    Physiol Res; 1992; 41(4):267-72. PubMed ID: 1363058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some metabolic effects of metipranolol, propranolol, alprenolol, oxprenolol, and practolol in rats.
    Siblíková O; Trcka V
    Acta Univ Carol Med (Praha); 1980; 26(5-6):259-70. PubMed ID: 6126105
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
    Trcka V; Vanĕcek M; Helfert I; Mácová S
    Acta Univ Carol Med (Praha); 1980; 26(5-6):239-58. PubMed ID: 6126104
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of the effect of eleven beta-adrenoceptor blocking drugs in perturbing lipid membrane: an ESR spectroscopy study.
    Ondrias K; Stasko A; Jancinová V; Balgavý P
    Mol Pharmacol; 1987 Jan; 31(1):97-102. PubMed ID: 2880287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allium ursinum L.: bioassay-guided isolation and identification of a galactolipid and a phytosterol exerting antiaggregatory effects.
    Sabha D; Hiyasat B; Grötzinger K; Hennig L; Schlegel F; Mohr FW; Rauwald HW; Dhein S
    Pharmacology; 2012; 89(5-6):260-9. PubMed ID: 22507958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 4 beta-adrenoceptor blocking drugs on blood pressure and exercise heart rate in hypertension.
    Harry JD; Knapp MF; Linden RJ; Stoker JB; Newcombe C
    Eur J Cardiol; 1979 Aug; 10(2):131-41. PubMed ID: 38965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of blood platelet functions by cationic amphiphilic drugs in relation to their physico-chemical properties.
    Jancinová V; Májeková M; Nosál R; Petríková M
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):191-3. PubMed ID: 8735816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.